Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis

Marina Serper, Sunny Y. Tao, Dorothea S. Kent, Patrik Garren, Alexander E. Burdzy, Jennifer C. Lai, Amir Gougol, Pamela M. Bloomer, K. Rajender Reddy, Michael A. Dunn, Andres Duarte‐Rojo – 20 May 2021 – Objective inpatient frailty assessments in decompensated cirrhosis are understudied. We examined the feasibility of inpatient frailty measurements and associations with nonhome discharge, readmission, and all‐cause mortality among patients admitted for cirrhosis complications. We conducted a prospective study at 3 liver transplantation (LT) centers.

Standardized Feeding Protocol Improves Delivery and Acceptance of Enteral Nutrition in Children Immediately After Liver Transplantation

Mar Miserachs, Penni Kean, Lori Tuira, Yasser Al Nasser, Maria De Angelis, Krista Van Roestel, Anand Ghanekar, Mark Cattral, Marialena Mouzaki, Vicky Lee Ng, Haifa Mtaweh, Yaron Avitzur – 20 May 2021 – Delivery of adequate nutrition after liver transplantation (LT) surgery is an important goal of postoperative care. Existing guidelines recommend early enteral nutrition after abdominal surgery and in the child who is critically ill but data on nutritional interventions after LT in children are sparse.

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

Aurélie Walter, Marika Rudler, Pol Olivas, Lucile Moga, Eric Trépo, Marie Angèle Robic, Isabelle Ollivier‐Hourmand, Anna Baiges, Olivier Sutter, Charlotte Bouzbib, Jean Marie Peron, Vincent Le Pennec, Nathalie Ganne‐Carrié, Juan Carlos Garcia‐Pagán, Maxime Mallet, Hélène Larrue, Thong Dao, Dominique Thabut, Virginia Hernández‐Gea, Jean‐Charles Nault, Christophe Bureau, Manon Allaire, the Salvage TIPS Group – 20 May 2021

TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard‐of‐Care Therapy

Gabriel M. Knight, Jeffrey Clark, Justin R. Boike, Haripriya Maddur, Daniel R. Ganger, Abhinav Talwar, Ahsun Riaz, Kush Desai, Samdeep Mouli, Elias Hohlastos, Juan‐Carlos Garcia Pagan, Ahmed Gabr, Brady Stein, Robert Lewandowski, Bartley Thornburg, Riad Salem – 20 May 2021

LiverLearning®: 2021 Webinar: Challenges in NASH Clinical Trials

Join the Nonalcoholic Fatty Liver Disease Special Interest Group in discussing the current challenges in histological assessment in NASH clinical trials. Presenters will also discuss how to implement hard outcomes in NASH clinical trials and the use non-invasive biomarkers as primary endpoints for drug approval.Naim Alkhouri Naim Alkhouri, MD is the VP of Academic Affairs, Chief of Transplant Hepatology, and Director of the Fatty Liver Program at Arizona Liver Health (ALH) in Phoenix, AZ. Prior to joining ALH, Dr.

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

Lukas Hartl, Georg Semmler, Benedikt Silvester Hofer, Nawa Schirwani, Mathias Jachs, Benedikt Simbrunner, David Josef Maria Bauer, Teresa Binter, Katharina Pomej, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Bernhard Scheiner – 17 May 2021 – The coronavirus disease 2019 (COVID‐19) pandemic necessitated down‐scaling of in‐hospital care to prohibit the spread of severe acute respiratory syndrome–coronavirus‐2.

Subscribe to